No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr13:30700200-30717200 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
2 |
chr13:30707400-30714400 |
Weak transcription |
Spleen |
Spleen
|
3 |
chr13:30707400-30714400 |
Weak transcription |
GM12878-XiMat |
blood
|
4 |
chr13:30707800-30715200 |
Weak transcription |
Dnd41 |
blood
|
5 |
chr13:30708000-30714400 |
Weak transcription |
Primary T cells fromperipheralblood |
blood
|
6 |
chr13:30708800-30715600 |
Weak transcription |
Brain Cingulate Gyrus |
brain
|
7 |
chr13:30708800-30716800 |
Weak transcription |
Brain Anterior Caudate |
brain
|
8 |
chr13:30709400-30715600 |
Weak transcription |
Cortex derived primary cultured neurospheres |
brain
|
9 |
chr13:30709600-30714600 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
10 |
chr13:30709600-30715200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
11 |
chr13:30711600-30712600 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
12 |
chr13:30711600-30712800 |
Enhancers |
Osteobl |
bone
|
13 |
chr13:30712000-30712800 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
14 |
chr13:30712200-30712800 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
15 |
chr13:30712200-30712800 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
16 |
chr13:30712200-30712800 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
17 |
chr13:30712200-30712800 |
Enhancers |
Adipose Nuclei |
Adipose
|
18 |
chr13:30712200-30712800 |
Enhancers |
Brain Substantia Nigra |
brain
|
19 |
chr13:30712200-30712800 |
Enhancers |
Placenta |
Placenta
|
20 |
chr13:30712200-30712800 |
Enhancers |
Lung |
lung
|
21 |
chr13:30712200-30712800 |
Flanking Active TSS |
Hela-S3 |
cervix
|
22 |
chr13:30712200-30712800 |
Enhancers |
NH-A |
brain
|
23 |
chr13:30712200-30713000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
24 |
chr13:30712200-30713000 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
25 |
chr13:30712200-30713000 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
26 |
chr13:30712200-30713000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
27 |
chr13:30712200-30713000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
28 |
chr13:30712200-30713000 |
Enhancers |
A549 |
lung
|
29 |
chr13:30712200-30713000 |
Enhancers |
HUVEC |
blood vessel
|
30 |
chr13:30712400-30712600 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
31 |
chr13:30712400-30712600 |
Enhancers |
NHDF-Ad |
bronchial
|
32 |
chr13:30712400-30712800 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
33 |
chr13:30712400-30712800 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
34 |
chr13:30712400-30712800 |
Enhancers |
Fetal Lung |
lung
|
35 |
chr13:30712400-30713000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|